Table 2 General characteristics and baseline serological indicators of pregnant women with IH in the second trimester.

From: Effect of levothyroxine treatment on serum lipids and pregnancy outcomes in pregnant women with isolated hypothyroxinemia

General characteristics and baseline serological indicators

C2 group

(n = 101)

T2 group

(n = 95)

P

Age(year)

31(30, 33)

31(29, 32)

0.417

BMI(kg/m2)

22.96(21.48, 24.92)

22.94(21.58, 25.32)

0.625

cesarean section time(n)

0(0, 1)

0(0, 0)

0.109

confirmed gestational week(week)

18.0(17.0, 19.0)

18.0(16.4, 18.9)

0.379

FPG(mmol/l)

4.71 ± 0.43

4.72 ± 0.41

0.779

HbA1C(%)

5.0(4.8, 5.3)

5.0(4.7, 5.2)

0.789

FT4(pmol/L)

11.60(11.00, 11.90)

11.60(11.20, 11.90)

0.805

TSH(mIU/L)

1.78(1.29, 2.54)

2.28(1.40, 3.21)

0.056

TC(mmol/L)

5.02(4.48, 5.93)

4.92(4.34, 5.69)

0.299

TG(mmol/L)

1.88(1.48, 2.43)

1.89(1.52, 2.36)

0.953

HDL(mmol/L)

1.89(1.61, 2.14)

1.90(1.59, 2.12)

0.770

LDL(mmol/L)

3.07(2.70, 3.68)

3.00(2.53, 3.51)

0.411